United States· US:70954-480_2a612458-8b9a-4125-a783-44327a8166d9
Estazolam
A estazolam product containing estazolam, registered in United States by Novitium Pharma LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Estazolam is registered in 4 of 19 countries.
Countries holding a registration under ATC N05CD04 (estazolam), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Estazolam · ATC N05CD04
4 / 19 countries
- Franceprice
- Japan
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of estazolam costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Estazolam · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- FR France$0.15
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ESTAZOLAM
- Manufacturer
- Novitium Pharma LLC
- Country
- United States (US)
- ATC code
- N05CD04
- ATC class
- Estazolam
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117095448010100 TABLET in 1 BOTTLE (70954-480-10)
- ndc1170954-480-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
178 interactions on record for estazolam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Estazolam · interactions on record
178 records
- 4 severe
- 99 moderate
- 22 minor
- 53 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Estazolam in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandEstazolam EspefaChemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA
- FranceNUCTALON 2 mg, compriméCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- France · Nuctalon
- Italy · Esilgan
- Lithuania · Estazolam Tc
- Poland · Estazolam Espefa, Estazolam Polfarmex
- Portugal · Kainever
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8591f8b4-6da3-4237-9283-b2f1a4aef71d GET /v1/drugs/8591f8b4-6da3-4237-9283-b2f1a4aef71d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "ESTAZOLAM",
"productndc": "70954-480",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "ANDA074826",
"marketing_category": "ANDA"
}See everything about estazolam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.